— Know what they know.
Not Investment Advice

ARDX NASDAQ

Ardelyx, Inc.
1W: -1.7% 1M: +5.5% 3M: +10.8% YTD: +3.2% 1Y: +51.9% 3Y: +42.4% 5Y: +273.5%
$6.11
-0.24 (-3.78%)
 
Weekly Expected Move ±7.7%
$5 $6 $6 $7 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 53 · $1.5B mcap · 236M float · 1.60% daily turnover · Short 48% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$407M +22.1% ▲
5Y CAGR: +121.9%
Gross Profit
$368M +29.9% ▲
5Y CAGR: +118.3%
Operating Income
-$41M -46.6% ▼
Net Income
-$62M -57.4% ▼
EPS (Diluted)
$-0.26 -52.9% ▼
EBITDA
-$29M -74.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$10M$52M$124M$334M$407M
YoY Growth+33.4%+416.6%+138.6%+168.1%+22.1%
Cost of Revenue$1M$4M$18M$51M$40M
Gross Profit$9M$48M$107M$283M$368M
Gross Margin90.1%92.1%85.7%84.8%90.3%
R&D Expenses$91M$35M$36M$52M$72M
SG&A Expenses$72M$77M$134M$259M$337M
Operating Expenses$163M$112M$170M$311M$409M
Operating Income-$154M-$64M-$63M-$28M-$41M
Operating Margin-1528.6%-122.2%-50.8%-8.4%-10.1%
Interest Expense$5M$5M$9M$20M$28M
Income Before Tax-$158M-$67M-$66M-$39M-$61M
Tax Expense$4K$8K$547K$266K$969K
Net Income-$158M-$67M-$66M-$39M-$62M
Net Margin-1566.5%-128.9%-53.1%-11.7%-15.1%
EPS (Diluted)$-1.52$-0.42$-0.30$-0.17$-0.26
EBITDA-$151M-$61M-$55M-$17M-$29M
Shares Outstanding104M159M219M235M241M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms